Journal profile · MEDICINE, RESEARCH & EXPERIMENTAL
European Journal of Translational Myology
ISSN 2037-7452 · eISSN 2037-7460 · PAGEPress Publications · Italy
European Journal of Translational Myology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2 (journal website); fully open access; APC charged, amount not published; median 29 days to acceptance (57 articles, last 24 months); 97 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
European Journal of Translational Myology is published by PAGEPress Publications and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Muscle Physiology and Disorders, Muscle activation and electromyography studies and Exercise and Physiological Responses, together about 37.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Focus, Scope and Objectives The European Journal of Translational Myology (previously published as Basic and Applied Myology) is recognized as the authoritative European forum in the field of Translational Myology. The journal provides a comprehensive platform for the dissemination of high-quality research addressing muscle biology and pathology across multiple levels of investigation, including fundamental, cellular, molecular, genetic, clinical, and translational studies. Its scope encompasses a broad array of article types, such as original research papers, systematic and narrative reviews, editorials, viewpoints, methodological protocols, rapid communications, comments, and letters to the editor. Through this multifaceted approach, the journal fosters scholarly exchange and advances the integration of basic and applied knowledge into clinical and translational practice. Peer review process Peer review is applied to all research articles and the majority of other article types published in PAGEPress journals. This usually entails at least two independent, expert peer reviewers. Policy All submissions to PAGEPress journals are first checked for completeness (criteria for desk reject are available in the Guide for Authors) before being sent to an Editor, who decides whether they are suitable for peer review. If an Editor is on the author list or has a competing interest in a particular manuscript, another member of the Editorial Board will be assigned to oversee peer review. When making a decision, Editors will consider the peer-reviewed reports, but they will not be bound by the opinions or recommendations contained in them. A single peer reviewer's or the Editor's concern may result in the manuscript being rejected. Peer review reports are sent to authors along with the editorial decision on their manuscript. EJTM uses the single-blind peer-review: the reviewers know the names of the authors, but the authors do not know who reviewed their manuscript. Selection Peer reviewer selection is critical to the publication process. A variety of factors influence it, including expertise, reputation, specific recommendations, conflicts of interest, and previous performance. All of these qualities are highly desirable: speed, thoroughness, sound reasoning, and collegiality. When two independent peer reviewers cannot be obtained, the Editor may act as a second reviewer or make a decision based on only one report. If acting as a second reviewer, the editor must have
From the journal's Aims & Scope
Research area (LetPub): MEDICINE, RESEARCH & EXPERIMENTAL
Editor-in-chief Ugo CarraroPublisher website
Editorial board by country: none in mainland China; most named Italy 17, United States 2, United Kingdom 1, France 1, Poland 1 (25 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Muscle Physiology and DisordersBiochemistry, Genetics and Molecular Biology18.6%
- Muscle activation and electromyography studiesEngineering12.9%
- Exercise and Physiological ResponsesMedicine6%
- Nutrition and Health in AgingMedicine4.8%
- Fibromyalgia and Chronic Fatigue Syndrome ResearchMedicine4.3%
- Genetic Neurodegenerative DiseasesNeuroscience4.1%
- Sports Performance and TrainingMedicine4%
- Sports injuries and preventionMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCPublisher website
Other: Google Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2Publisher website ·
- CiteScore 2026-06
- 4.1LetPub ·
- CiteScore (publisher)
- 4.1Publisher website ·
- SJR 2026-06
- 0.58LetPub ·
- SNIP 2026-06
- 0.78LetPub ·
- h-index
- 39OpenAlex ·
- i10-index
- 266OpenAlex ·
- 2-year mean citedness
- 0.74OpenAlex ·
- Self-citation rate
- 10%LetPub ·
- Share of gold OA articles
- 93.53%LetPub ·
Volume
- Articles per year
- 52LetPub ·
Articles by year OpenAlex count · 1,054 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 195 | 195 | 9 |
| 2025 | 97 | 97 | 51 |
| 2024 | 76 | 76 | 211 |
| 2023 | 71 | 71 | 510 |
| 2022 | 82 | 82 | 940 |
| 2021 | 69 | 69 | 555 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
29 daysMedian, submission to acceptance · P25–P75 17 days – 51 days
- Acceptance to online
- median 63 days (57 articles)
- Submission to online
- median 101 days
- Sample
- 57 articles with submission and acceptance dates (129 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 10 weeksLetPub ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 600 | Yes | CC BY-NC | |
| OpenAlex | EUR 350 | — | — | |
| LetPub | EUR 350 | No | — | |
| Publisher website | EUR 600 | — | — |
Other charges and waivers (author guidelines)
- Submission fee
- EUR 30
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare8 items from the author guidelines
- Abstract
- ≤ 180 words
- Manuscript length
- ≤ 3,500 words
- Reference style
- Author–date
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Highlights
- Required
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted4, with length limits
- letters to the editor800 words max. These are written on invitation, short essays that express the authors’ viewpoint, may respond to published manuscripts in our journals, or deliv…main text ≤ 800 words
- original articlesubmitted upon submission of the paper. Original Articles 3500 words max, abstract 180 words max, 30 references max, 3/5 tablesmain text ≤ 3,500 words · abstract ≤ 180 words · references ≤ 30
- protocolshould be listed in an ad hoc Appendix. Protocols 3500 words max, abstract 180 words max, 30 references max, 3 tables anmain text ≤ 3,500 words · abstract ≤ 180 words · references ≤ 30
- review4000 words max, abstract 250 words max, minimum 40 references, 3/5 tables and/or figures. They should be introduced by a general summary of content in the form …main text ≤ 4,000 words · abstract ≤ 250 words · references ≤ 40
Policy excerpts from the journal's websitePublication ethics, License & copyright, Open access, Peer review
- Publication ethics Misconduct
False or misleading information, such as identity theft and suggesting fake peer-reviewers, will result in the manuscript being rejected, further investigation in accordance with PAGEPress' misconduct policy (https://www.pagepress.org/site/plagiarism_misconduct), and notification to the authors' institutions/employers. PAGEPress journals follow the Committee on Publication Ethics (COPE) guidance a…
Source ↗Publisher website ·- License & copyright Copyright Notice
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published. An Open Access Publication is one that meets the following two conditions: the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit …
Source ↗Publisher website ·- Open access Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Source ↗Publisher website ·- Peer review Peer review process
Peer review is applied to all research articles and the majority of other article types published in PAGEPress journals. This usually entails at least two independent, expert peer reviewers. Policy All submissions to PAGEPress journals are first checked for completeness (criteria for desk reject are available in the Guide for Authors) before being sent to an Editor, who decides whether they are su…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- PAGEPress Publications
- Country or region
- Italy
- Language
- English
- ISSN
- 2037-7452
- Electronic ISSN
- 2037-7460
- Latest issue on the website
- Volume 36, Issue 2 (2026)
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗DOAJ
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about European Journal of Translational Myology
What CAS zone is European Journal of Translational Myology in?
In the 2025 upgraded edition of the CAS Journal Ranking, European Journal of Translational Myology is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of European Journal of Translational Myology?
The journal's website gives an impact factor of 2; this is the journal's own figure, as LetPub lists none for it; CiteScore 4.1, h-index 39.
How long does peer review take at European Journal of Translational Myology?
Based on the dates recorded on 57 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 29 days (interquartile range 17–51 days); authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of European Journal of Translational Myology?
According to the journal's author guidelines: Abstract: ≤ 180 words; Manuscript length: ≤ 3,500 words; Reference style: Author–date; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Highlights: Required; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of European Journal of Translational Myology based?
Of the 25 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Italy (17), United States (2) and United Kingdom (1). Counted from the institutions listed on the board page; for reference only.
Which databases index European Journal of Translational Myology?
According to LetPub and DOAJ records, European Journal of Translational Myology is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science and PMC; that list has not been checked against each database.
Is European Journal of Translational Myology open access, and what is the APC?
European Journal of Translational Myology is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .